Professor, School of Medicine, Grififith University, Broad Beach, Queens land, Australia; and Profes, Chair Medical Law Sechenov Moscow First State University, Moscow, Russia
Review Article
What is Epilepsy – when do we start treatment and with what?
Author(s): Roy G Beran*
Introduction: Epilepsy comprises ≥ 2 unprovoked seizures (>24 h apart), 1 unprovoked seizure with probability of recurrence (≥ 60%) or an epilepsy syndrome. What follows is consideration of treatment.
Background: Newer ASMs offer adjunctive treatment but none has better efficacy than carbamazepine (CBZ) although possibly less adverse effects. Valproate (VPA) is preferred for generalised epilepsy (except child-bearing age women) with increased preference for the levetiracetam and lamotrigine (LTG). Despite decline for older ASMs, Beran supported CBZ.
First unprovoked seizure has 30-50% chance of recurrence, rising to 70-80% with a second seizure. Percentages increase with abnormal neurologic examination, focal spikes on electroencephalography (EEG) and focal seizures.
Most common epilepsy presentation to the emerg.. Read More»
DOI:
10.37421/2472-0895.2021.7.141
Epilepsy Journal received 41 citations as per Google Scholar report